−0.133 SEK
−44.05 M SEK
0.00 SEK
About ANNEXIN PHARMACEUTICALS AB
Sector
CEO
Nils Anders Haegerstrand
Headquarters
Stockholm
Website
Founded
2014
ISIN
SE0009664154
FIGI
BBG00GGV2H53
Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale production of Annexin A5. The company was founded by Anna Frostegård in 2014 and is headquartered in Stockholm, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ANNX is 0.433 SEK — it has increased by 5.61% in the past 24 hours. Watch ANNEXIN PHARMACEUTICALS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ANNEXIN PHARMACEUTICALS AB stocks are traded under the ticker ANNX.
ANNX stock has fallen by −6.28% compared to the previous week, the month change is a −14.43% fall, over the last year ANNEXIN PHARMACEUTICALS AB has showed a 60.70% increase.
ANNX reached its all-time high on Sep 22, 2017 with the price of 4.958 SEK, and its all-time low was 0.172 SEK and was reached on Oct 24, 2023. View more price dynamics on ANNX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ANNX stock is 38.19% volatile and has beta coefficient of 0.52. Track ANNEXIN PHARMACEUTICALS AB stock price on the chart and check out the list of the most volatile stocks — is ANNEXIN PHARMACEUTICALS AB there?
Today ANNEXIN PHARMACEUTICALS AB has the market capitalization of 230.78 M, it has increased by 3.44% over the last week.
Yes, you can track ANNEXIN PHARMACEUTICALS AB financials in yearly and quarterly reports right on TradingView.
ANNX net income for the last quarter is −10.93 M SEK, while the quarter before that showed −14.51 M SEK of net income which accounts for 24.71% change. Track more ANNEXIN PHARMACEUTICALS AB financial stats to get the full picture.
No, ANNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 4.00 employees. See our rating of the largest employees — is ANNEXIN PHARMACEUTICALS AB on this list?
Like other stocks, ANNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANNEXIN PHARMACEUTICALS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANNEXIN PHARMACEUTICALS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANNEXIN PHARMACEUTICALS AB stock shows the sell signal. See more of ANNEXIN PHARMACEUTICALS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.